Apolipoprotein A-I inhibits LPS-induced atherosclerosis in ApoE−/− mice possibly via activated STAT3-mediated upregulation of tristetraprolin
Kai Yin(Shanghai Jiao Tong University), Chao‐Ke Tang(University of South China), Rongfang He(University of South China), Jian Tu(University of South China), Qingjun Gui(University of South China), Xiaohua Yu(Qujiang People's Hospital), Di Xie(Xuzhou Medical College), Shilin Tang(Wuzhou Red Cross Hospital), Jinfeng Li(Hebei Medical University), Yuchang Fu(Medical University of South Carolina), Zhi‐Sheng Jiang(First Affiliated Hospital of University of South China), Guang-hui Tu
Cited by 36
Related Papers
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
|The Lancet Diabetes & Endocrinology|2019|383
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218
Long non-coding RNA Linc-RAM enhances myogenic differentiation by interacting with MyoD
|Nature Communications|2017|187